Aminex Therapeutics Inc.

United States of America (USA)

1 February 2018 - 31 January 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Aminex Therapeutics Inc. published between 1 February 2018 - 31 January 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC FC
1 0.03

Outputs by subject (FC)

Subject AC FC
Life Sciences 1 0.03

Top articles by Altmetric score in current window

Article has an altmetric score of 252

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

Science Translational Medicine

2019-01-30

1 February 2018 - 31 January 2019

International vs. domestic collaboration by FC

  • 11.85% Domestic
  • 88.15% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by FC (4 total)

  • Aminex Therapeutics Inc., United States of America (USA)
  • Domestic institution
  1. Harvard University, United States of America (USA) (0.06)
    0.03
    0.03
  2. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA) (0.06)
    0.03
    0.03
  3. Children's Hospital of Philadelphia (CHOP), United States of America (USA) (0.05)
    0.03
    0.02
  4. University of Pennsylvania (Penn), United States of America (USA) (0.05)
    0.03
    0.02

Top 10 international collaborators by FC (8 total)

  • Aminex Therapeutics Inc., United States of America (USA)
  • Foreign institution
  1. University of New South Wales (UNSW), Australia (0.47)
    0.03
    0.44
  2. Lowy Cancer Research Centre, Australia (0.46)
    0.03
    0.43
  3. Children's Cancer Institute Australia (CCIA), Australia (0.24)
    0.03
    0.21
  4. University of Bologna (UNIBO), Italy (0.18)
    0.03
    0.15
  5. University of Cologne (UoC), Germany (0.09)
    0.03
    0.06
  6. Garvan Institute of Medical Research, Australia (0.06)
    0.03
    0.03
  7. University of Technology, Sydney (UTS), Australia (0.04)
    0.03
    0.01
  8. NSW Health Pathology, Australia (0.04)
    0.03
    0.01

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Aminex Therapeutics Inc.
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER